Sarah H. Tannehill‐Gregg

Urothelial Carcinogenesis in the Urinary Bladder of Male Rats Treated with Muraglitazar, a PPARα/γ Agonist: Evidence for Urolithiasis as the Inciting Event in the Mode of Action

Mark A. Dominick, Melvin R. White, Thomas P. Sanderson et al. · Toxicologic Pathology · 2006 · 92 citations · Full text

Molecular Pharmacology, Urological Research, Urology +14

New bone formation and osteolysis by a metastatic, highly invasive canine prostate carcinoma xenograft

Bruce E. LeRoy, Nanda K. Thudi, Murali V.P. Nadella et al. · The Prostate · 2006 · 73 citations

Bone morphogenetic protein 3B silencing in non-small-cell lung cancer

Zunyan Dai, Anthony P. Popkie, Wei‐Guo Zhu et al. · Oncogene · 2004 · 59 citations

Tumor Biology, Non-small-cell Lung Cancer, Bronchial Neoplasm +5

Bone-Invasive Oral Squamous Cell Carcinoma in Cats

Chelsea K. Martin, Sarah H. Tannehill‐Gregg, Tobie D. Wolfe et al. · Veterinary Pathology · 2010 · 57 citations

Feline Oscc, Medicine, Oral Cavity +12

Rodent Carcinogenicity Profile of the Antidiabetic Dual PPAR α and γ Agonist Muraglitazar

Sarah H. Tannehill‐Gregg, Thomas P. Sanderson, Daniel J. Minnema et al. · Toxicological Sciences · 2007 · 51 citations

Molecular Pharmacology, Urology, Oncology +15